Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Amgen’s Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning

By Vandana Singh
January 19, 2:29 PM
FDA issues serious warning on Amgen's Prolia drug, highlighting increased risk of low calcium levels in specific patient groups.

AMGN

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Healthcare Giant Eli Lilly Under FDA Lens Again For Manufacturing Lapses

By Vandana Singh
January 19, 2:21 PM
Eli Lilly faces FDA scrutiny with eight deficiencies at its Branchburg plant, raising concerns on Emgality's manufacturing.

LLY

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca Tries To Reach New Ground For Its Lead Cancer Drug Imfinzi With New Data In Liver Cancer Study

By Vandana Singh
January 19, 1:41 PM
Explore results from AstraZeneca's EMERALD-1 Phase 3 trial on Imfinzi for unresectable hepatocellular carcinoma. Statistically significant improvement in progression-free survival with Imfinzi plus TACE and bevacizumab. Presented at ASCO Gastrointestinal Cancers Symposium.

AZN

Read More
3 minute read
  • Analyst Color
  • Equities
  • Gaming
  • General
  • Health Care
  • Large Cap
  • M&A
  • Markets
  • News
  • Social Media
  • Tech
  • Top Stories

AI Stocks Dominate In January: Nvidia, Juniper, Palo Alto Lead The Charge

By Neil Dennis
January 19, 10:37 AM
Tech stocks are propelling the S&P 500 index toward a new record high, and not all companies are from the small group of mega caps.

AMD

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Weightloss Drugs Ozempic And Wegovy’s Success Sets Novo Nordisk’s Owner To Utilize Dividend Windfall For Strategic Investments

By Vandana Singh
January 19, 9:30 AM
Explore Novo Holdings' 2024 plans for acquisitions and investments in Asia, led by CEO Kasim Kutay. Discover strategic initiatives, global studies on NVO drugs, and insights into challenges and opportunities.

NVO

Read More
2 minute read
  • General
  • Health Care
  • Media
  • News
  • Tech
  • Top Stories

Masimo CEO ‘Wholeheartedly’ Feels Apple Watch Users Are Better Off Without Blood Oxygen Monitoring Feature

By Rounak Jain
January 19, 2:29 AM
"Pulse oximetry is not useful unless it is a continuous monitor. That happens during sleep," Kiani explained.

AAPL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Equities
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Halozyme’s Ambitious Five-Year Plan: Analysts Optimistic On Growth, Eyeing Market Expansion

By Vandana Singh
January 18, 2:28 PM
Explore Halozyme Therapeutics' promising financial outlook up to 2028. Discover revenue forecasts, earnings projections, and market insights.

ARGX

Read More
3 minute read
  • Economics
  • Equities
  • General
  • Government
  • Health Care
  • Large Cap
  • Markets
  • News
  • Top Stories

Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?

By Neil Dennis
January 18, 1:48 PM
Pharmaceuticals prices are already up in 2024: Can inflation-beating hikes be justified?

BMY

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News

Why Is Cancer Focused Novocure Stock Trading Higher Today?

By Vandana Singh
January 18, 1:19 PM
Novocure's TTFields therapy gains FDA acceptance for non-small cell lung cancer treatment after platinum-based therapy. PMA filing under FDA review. Decision expected in 2H 2024.

NVCR

Read More
2 minute read
  • General
  • Government
  • Health Care
  • Large Cap
  • Markets
  • News
  • Regulations

Medicare Patients Alert! Biden Administration Finalizes Rule to Streamline Health Insurance Prior Authorization

By Vandana Singh
January 18, 11:23 AM
Biden Administration's rule for health information exchange and prior authorization processes in government-backed insurance plans. Streamlined procedures, reduced wait times, and estimated $15 billion savings by 2026.

CI

Posts pagination

Previous 1 … 75 76 77 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service